SLDB logo

Solid Biosciences Inc. (SLDB) EBITDA

annual EBITDA:

-$121.90M-$28.91M(-31.09%)
December 31, 2024

Summary

  • As of today (September 16, 2025), SLDB annual EBITDA is -$121.90 million, with the most recent change of -$28.91 million (-31.09%) on December 31, 2024.
  • During the last 3 years, SLDB annual EBITDA has fallen by -$52.61 million (-75.93%).
  • SLDB annual EBITDA is now -1757.13% below its all-time high of -$6.56 million, reached on December 31, 2015.

Performance

SLDB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLDBincome statement metrics

quarterly EBITDA:

-$41.31M-$1.66M(-4.19%)
June 30, 2025

Summary

  • As of today (September 16, 2025), SLDB quarterly EBITDA is -$41.31 million, with the most recent change of -$1.66 million (-4.19%) on June 30, 2025.
  • Over the past year, SLDB quarterly EBITDA has dropped by -$14.75 million (-55.56%).
  • SLDB quarterly EBITDA is now -915.16% below its all-time high of -$4.07 million, reached on March 1, 2016.

Performance

SLDB quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLDBincome statement metrics

TTM EBITDA:

-$155.14M-$14.75M(-10.51%)
June 30, 2025

Summary

  • As of today (September 16, 2025), SLDB TTM EBITDA is -$155.14 million, with the most recent change of -$14.75 million (-10.51%) on June 30, 2025.
  • Over the past year, SLDB TTM EBITDA has dropped by -$57.84 million (-59.46%).
  • SLDB TTM EBITDA is now -3712.66% below its all-time high of -$4.07 million, reached on March 1, 2016.

Performance

SLDB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLDBincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

SLDB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-31.1%-55.6%-59.5%
3 y3 years-75.9%-78.5%-87.0%
5 y5 years-4.6%-134.2%-52.1%

SLDB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-75.9%at low-99.6%at low-87.0%at low
5 y5-year-75.9%at low-155.7%at low-123.9%at low
alltimeall time-1757.1%at low-915.2%at low-3712.7%at low

SLDB EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$41.31M(+4.2%)
-$155.14M(+10.5%)
Mar 2025
-
-$39.65M(+0.6%)
-$140.38M(+10.3%)
Dec 2024
-$121.90M(+31.1%)
-$39.41M(+13.3%)
-$127.27M(+16.2%)
Sep 2024
-
-$34.78M(+31.0%)
-$109.54M(+12.6%)
Jun 2024
-
-$26.55M(+0.1%)
-$97.29M(+0.4%)
Mar 2024
-
-$26.54M(+22.4%)
-$96.94M(-4.4%)
Dec 2023
-$92.99M(-4.0%)
-$21.68M(-3.8%)
-$101.36M(-6.2%)
Sep 2023
-
-$22.53M(-14.0%)
-$108.05M(+1.7%)
Jun 2023
-
-$26.20M(-15.3%)
-$106.22M(+3.0%)
Mar 2023
-
-$30.95M(+9.1%)
-$103.16M(+6.5%)
Dec 2022
-$96.87M(+39.8%)
-$28.37M(+37.1%)
-$96.87M(+12.1%)
Sep 2022
-
-$20.69M(-10.6%)
-$86.39M(+4.1%)
Jun 2022
-
-$23.14M(-6.2%)
-$82.97M(+6.6%)
Mar 2022
-
-$24.66M(+37.8%)
-$77.80M(+12.3%)
Dec 2021
-$69.29M(-16.1%)
-$17.89M(+3.5%)
-$69.29M(-3.7%)
Sep 2021
-
-$17.28M(-3.8%)
-$71.95M(-4.2%)
Jun 2021
-
-$17.97M(+11.2%)
-$75.13M(+0.4%)
Mar 2021
-
-$16.15M(-21.4%)
-$74.80M(-9.4%)
DateAnnualQuarterlyTTM
Dec 2020
-$82.54M(-29.1%)
-$20.55M(+0.4%)
-$82.54M(-11.7%)
Sep 2020
-
-$20.46M(+16.0%)
-$93.51M(-8.3%)
Jun 2020
-
-$17.64M(-26.2%)
-$102.01M(-7.8%)
Mar 2020
-
-$23.89M(-24.2%)
-$110.68M(-5.0%)
Dec 2019
-$116.49M(+57.2%)
-$31.52M(+8.9%)
-$116.49M(+9.0%)
Sep 2019
-
-$28.95M(+10.0%)
-$106.88M(+10.7%)
Jun 2019
-
-$26.31M(-11.4%)
-$96.53M(+9.6%)
Mar 2019
-
-$29.71M(+35.6%)
-$88.08M(+18.8%)
Dec 2018
-$74.12M(+36.2%)
-$21.91M(+17.7%)
-$74.12M(+10.4%)
Sep 2018
-
-$18.61M(+4.1%)
-$67.15M(+8.1%)
Jun 2018
-
-$17.86M(+13.5%)
-$62.13M(+10.8%)
Mar 2018
-
-$15.75M(+5.4%)
-$56.09M(+3.1%)
Dec 2017
-$54.41M(+113.2%)
-$14.94M(+10.0%)
-$54.41M(+13.0%)
Sep 2017
-
-$13.59M(+14.9%)
-$48.16M(+39.3%)
Jun 2017
-
-$11.82M(-15.9%)
-$34.57M(+52.0%)
Mar 2017
-
-$14.06M(+61.9%)
-$22.75M(+78.3%)
Dec 2016
-$25.52M(+288.8%)
-$8.69M(+113.5%)
-$12.76M(+213.5%)
Mar 2016
-
-$4.07M
-$4.07M
Dec 2015
-$6.56M
-
-

FAQ

  • What is Solid Biosciences Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Solid Biosciences Inc.?
  • What is Solid Biosciences Inc. annual EBITDA year-on-year change?
  • What is Solid Biosciences Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Solid Biosciences Inc.?
  • What is Solid Biosciences Inc. quarterly EBITDA year-on-year change?
  • What is Solid Biosciences Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Solid Biosciences Inc.?
  • What is Solid Biosciences Inc. TTM EBITDA year-on-year change?

What is Solid Biosciences Inc. annual EBITDA?

The current annual EBITDA of SLDB is -$121.90M

What is the all time high annual EBITDA for Solid Biosciences Inc.?

Solid Biosciences Inc. all-time high annual EBITDA is -$6.56M

What is Solid Biosciences Inc. annual EBITDA year-on-year change?

Over the past year, SLDB annual EBITDA has changed by -$28.91M (-31.09%)

What is Solid Biosciences Inc. quarterly EBITDA?

The current quarterly EBITDA of SLDB is -$41.31M

What is the all time high quarterly EBITDA for Solid Biosciences Inc.?

Solid Biosciences Inc. all-time high quarterly EBITDA is -$4.07M

What is Solid Biosciences Inc. quarterly EBITDA year-on-year change?

Over the past year, SLDB quarterly EBITDA has changed by -$14.75M (-55.56%)

What is Solid Biosciences Inc. TTM EBITDA?

The current TTM EBITDA of SLDB is -$155.14M

What is the all time high TTM EBITDA for Solid Biosciences Inc.?

Solid Biosciences Inc. all-time high TTM EBITDA is -$4.07M

What is Solid Biosciences Inc. TTM EBITDA year-on-year change?

Over the past year, SLDB TTM EBITDA has changed by -$57.84M (-59.46%)
On this page